3 Healthcare Stocks That Fall Short

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destocking have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 1.2% has lagged the S&P 500’s 9.8% climb.